drugset
drugset / Trial / NCT03053700

Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of Rosacea

NCT03053700 ↗

Phase 4 Withdrawn Rabin Medical Center
Non-randomizedSingle-groupSingle-blindTreatment

Summary

This is an interventional and prospective study. The study is designed to evaluate the additional benefits of a combination of IPL treatment and local application of Bromonide 0.33% gel in the treatment of erythematotelangiectatic (ETR) and papulopustular (PPR).

Timeline

Start
2018-12-01
Primary completion
2019-01-02
Completion
2019-01-02

Outcome

Outcome not reported

Stopped: “During study new treatments were available, which may be more effective than proposed study treatment.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bromonide Unknown 0.33 % Topical

Indications

rosacea